Presentation slides Introduction The prevalence of cutaneous manifestations of diabetes mellitus both Type 1 and Type 2 ranges between 30 to 70 The clinical features and underlying mechanism of these dermatologic features of diabetes mellitus will be described next ID: 1008978
Download Presentation The PPT/PDF document "Dermatologic manifestations of diabetes ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1. Dermatologic manifestations of diabetes mellitusPresentation slides
2. IntroductionThe prevalence of cutaneous manifestations of diabetes mellitus (both Type 1 and Type 2) ranges between 30 to 70%. The clinical features and underlying mechanism of these dermatologic features of diabetes mellitus will be described next.
3. Acanthosis nigricansFeatureNotesDescriptionPoorly delineated plaques with a grey to dark-brown pigmentation. Typically has a velvety texture. LocationIntertriginous and other flexural areas (axilla, elbows, inframammary regions, palms – known as “Tripe palms”). MechanismInsulin activates IGF-1 receptors present on fibroblasts and keratinocytesAdditionally, hyperinsulinemia causes a decrease in IGF binding proteins, which results in a higher level of unbound (active) IGF-1 (vicious cycle)Androgens and growth factor receptors are present on keratinocytes and fibroblasts as well (may explain other hormonal causes of acanthosis nigricans)TreatmentImprovement in insulin resistance (metformin, dietary changes, increased physical activity, and weight reduction)
4. Diabetic dermopathyFeatureNotesDescriptionhyperpigmented and circumscribed red papules that change over 1-2 weeks into atrophic brown papulesLocationPretibial areaMechanismNeuropathy and microangiopathy induced by uncontrolled diabetes mellitusTreatmentIt is self-limited and largely asymptomatic, as such treatment is not required
5. Acrochordons (skin tags)FeatureNotesDescriptionPedunculated cutaneous fibromasLocationflexural areas in the neck and axilla, in a pattern akin to the distribution of acanthosis nigricansMechanismHyperinsulinemia promotes the activation of fibroblast bound IGF-1 receptors present in the epidermis. This is followed by the proliferation of skin fibroblasts and subsequent development of skin tags.TreatmentNo treatment is required
6. Necrobiosis lipoidica diabeticorum (NLD)FeatureNotesDescriptionA red-brown papule that progressively increases in diameter and eventually changes into the classic waxy, yellowish lesion. There is occasional central ulceration, which manifests as an atrophic center. Exhibits Koebnerization.LocationPresent almost always on pretibial areas of the lower extremitiesMechanismThere is initial tissue hypoperfusion in the skin due to microangiopathy involving skin capillaries. Microangiopathy occurs as a result of the accumulation of advanced glycated end products in the vasculature, which consequently promotes local oxidative stress. Inflammatory mediators which have accumulated in response to tissue hypoperfusion lead to a progressive breakdown in collagenTreatmentTopical or intra-lesional corticosteroids
7. LipodystrophyFeatureDescriptionDescriptionLocalized lipodystrophy due to insulin injections is an umbrella term that consists of the lipoatrophy (LA) and lipohypertrophy (LH) subtypes. LA tends to appear as an area of subcutaneous tissue loss, which creates a dimple in the skin. LH, however, has a firm, rubbery consistency that is palpable in the subcutaneous tissue plane. Occasionally, LH lesions may be soft, making them difficult to discern on routine physical examination.LocationSites of insulin injectionsMechanismLipoatrophy occurs as a result of an immune-mediated reaction to insulin; it is less prevalent now due to the use of modern human insulin or human-like insulin analogs.Lipohypertrophy is due to the growth-promoting effects of insulin on fibroblasts in the subcutaneous tissue. Insulin binds to IGF-1 receptors on fibroblasts which leads to the activation and subsequent proliferation of fibroblastsTreatmentRotation of sites of insulin injection
8. Bullosis DiabeticorumFeatureNotesDescriptionSudden onset of one or more non-erythematous, firm and sterile bullae containing a clear fluid. They may range in size from 0.5cm to 5cm.LocationUsually located on the lower extremitiesMechanismUnknown TreatmentThese can be aspirated for symptomatic relief.
9. Scleroderma diabeticorumFeatureNotesDescriptionThickened, waxy, or edematous indurated plaquesLocationDistributed over the neck and upper back. Diabetic hand syndrome, a form of scleroderma-like skin change of diabetes, may present with limited joint mobility, palmar fibromatosis (Dupuytren's contracture), or stenosing tenosynovitis (“trigger finger”) MechanismReduced breakdown of collagen fibers due to nonenzymatic glycosylation of dermal collagenTreatmentNone
10. Eruptive xanthomaFeatureNotesDescriptionYellowish papulesLocationLocated over the trunk and extensor surfaces such as the elbows and knees.MechanismReduced lipoprotein lipase activity due to insulin resistance or insulinopenia causes impaired storage of triglycerides in adipose tissue. As a consequence, triglycerides accumulate in the skin.TreatmentTreatment of diabetes. Surgical treatment in select cases